L
6.84
0.07 (1.03%)
| Previous Close | 6.77 |
| Open | 6.77 |
| Volume | 1,799,838 |
| Avg. Volume (3M) | 1,754,051 |
| Market Cap | 2,630,322,176 |
| Price / Earnings (Forward) | 100.00 |
| Price / Sales | 1.43 |
| Price / Book | 1.29 |
| 52 Weeks Range | |
| Earnings Date | 8 May 2025 - 13 May 2025 |
| Profit Margin | -2.78% |
| Operating Margin (TTM) | 0.48% |
| Diluted EPS (TTM) | -0.090 |
| Quarterly Revenue Growth (YOY) | 10.80% |
| Total Debt/Equity (MRQ) | 33.09% |
| Current Ratio (MRQ) | 1.47 |
| Operating Cash Flow (TTM) | 126.01 M |
| Levered Free Cash Flow (TTM) | 113.77 M |
| Return on Assets (TTM) | -0.33% |
| Return on Equity (TTM) | -2.47% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | LifeStance Health Group, Inc. | Mixed | Bearish |
AIStockmoo Score
-0.4
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.38 |
|
LifeStance Health Group Inc is a mental healthcare company focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 8.22% |
| % Held by Institutions | 93.25% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 9.00 (Keybanc, 31.58%) | Buy |
| Median | 8.50 (24.27%) | |
| Low | 8.00 (Canaccord Genuity, 16.96%) | Buy |
| Average | 8.50 (24.27%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 6.44 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| UBS | 27 May 2025 | 8.50 (24.27%) | Buy | 6.06 |
| Keybanc | 08 Apr 2025 | 9.00 (31.58%) | Buy | 6.53 |
| Canaccord Genuity | 03 Apr 2025 | 8.00 (16.96%) | Buy | 6.74 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 28 May 2025 | Announcement | LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference |
| 14 May 2025 | Announcement | LifeStance Names Vaughn Paunovich as Chief Technology Officer |
| 07 May 2025 | Announcement | LifeStance Reports First Quarter 2025 Results |
| 21 Apr 2025 | Announcement | LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025 |
| 15 Apr 2025 | Announcement | LifeStance Survey Finds Nearly One-Third of Americans Use Social Media Content to Self-Diagnose Mental Health Conditions |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |